Suraksha Diagnostic IPO Subscription Status

Suraksha Diagnostic IPO Subscription Status
Suraksha Diagnostic IPO subscription started on 29 November, 2024 and will close on 3 December, 2024. The retail quota is 35%, QIB is 50% and NII is 15%. Suraksha Diagnostic IPO got a lot of interest, raising around ₹846.25 Crores, with subscriptions 1.27 times overall, including 1.74 times by institutional investors, 1.4 times by non-institutional investors, and 0.94 times by retail investors. Shares are priced between ₹420-441 each and will be listed on the BSE and NSE.
  Check Live IPO  Subscription List  👈
Listed
Last Updated - December 3, 2024 11:55 pm

Suraksha Diagnostic IPO Subscription - Day 3

QIB - Qualified Institutional Buyers: 1.74x
NII - Non-Institutional Investors: 1.4x
SNII - Small Non-Institutional Investors: 1.16x
BNII - Big Non-Institutional Investors: 1.53x
RII - Retail Individual Investor: 0.94x
Total: 1.27x 👈

Suraksha Diagnostic IPO Investor Categories

  • Qualified Institutional Buyers: QIB
  • Non-Institutional Investors: NII
  • Small Non-Institutional Investors: SNII- Bid below ₹10L
  • Big Non-Institutional Investors: BNII- Bid above ₹10L
  • Retail Individual Investor: RII
  • Employees Quota: EMP

Suraksha Diagnostic IPO Dates

IPO Activity Date
Open Date: 29 November, 2024
Close Date: 3 December, 2024
Allotment Date: 4 December, 2024
Refund Date: 5 December, 2024
Shares Credit Date: 5 December, 2024
Listing Date: 6 December, 2024

Suraksha Diagnostic IPO Subscription Status FAQs

Q.When Suraksha Diagnostic IPO Subscription will start?

Ans.The IPO subscription starts on 29 November, 2024 for Investors.


Q.What is the Suraksha Diagnostic IPO Subscription last date?

Ans.Suraksha Diagnostic IPO subscription last date is 3 December, 2024 for Investors.


Q.What is the Suraksha Diagnostic IPO Allotment Date?

Ans.Suraksha Diagnostic IPO allotment date is 4 December, 2024.


Q.What is the Suraksha Diagnostic IPO Listing Date?

Ans.Suraksha Diagnostic IPO listing date is 6 December, 2024. The IPO is to list on BSE and NSE.

Leave a Comment

Your email address will not be published. Required fields are marked *